Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04104893
Title A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation (CHOMP)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors VA Office of Research and Development
Indications

prostate adenocarcinoma

prostate small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Greater Los Angeles Healthcare System, West Los Angeles, CA Recruiting West Los Angeles California 90073 United States Details
Bay Pines VA Healthcare System, Pay Pines, FL Recruiting Bay Pines Florida 33744 United States Details
Jesse Brown VA Medical Center, Chicago, IL Recruiting Chicago Illinois 60612 United States Details
VA Ann Arbor Healthcare System, Ann Arbor, MI Recruiting Ann Arbor Michigan 48105 United States Details
James J. Peters VA Medical Center, Bronx, NY Recruiting Bronx New York 10468 United States Details
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY Recruiting New York New York 10010 United States Details
Durham VA Medical Center, Durham, NC Recruiting Durham North Carolina 27705 United States Details
VA Puget Sound Health Care System Seattle Division, Seattle, WA Recruiting Seattle Washington 98108 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field